# Efficacy and Safety of Sodium Heparin in Patients Submitted to Heart Surgery Using Bypass

> **NCT00905216** · PHASE3 · UNKNOWN · sponsor: **Azidus Brasil** · enrollment: 104 (estimated)

## Conditions studied

- Cardiac Surgery

## Interventions

- **DRUG:** heparin sodium - Bergamo
- **DRUG:** heparin sodium - APP

## Key facts

- **NCT ID:** NCT00905216
- **Lead sponsor:** Azidus Brasil
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-06
- **Primary completion:** 2009-09
- **Final completion:** 2011-12
- **Target enrollment:** 104 (ESTIMATED)
- **Last updated:** 2011-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00905216

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00905216, "Efficacy and Safety of Sodium Heparin in Patients Submitted to Heart Surgery Using Bypass". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00905216. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*